Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged net income of $2.76 billion, or $3.06 a share, up ...

The company affirmed its target for 2025 normalized Ebitda of between C$1.775 billion and C$1.875 billion and said it continued to expect 5% to 7% compounded annual growth for its dividend through ...

Dow Jones futures rose solidly early Thursday, along with S&P 500 futures and Nasdaq futures as Meta Platforms, Microsoft rose solidly on earnings. Sprouts Farmers Market and Robinhood Markets also ...

Futures on Wall Street are extending their recovery from Wednesday, surging sharply in the after-market session. The Dow ...